Industry's Voice

Hardman_Mike_AstraZeneca_150x110.png

Mike Hardman, AstraZeneca

“The Pharmaceutical Industry recognized the need for greater competence
in integrated medicines development through high quality and standardised training throughout Europe – and thereby mastering the process.”

_______________________________________________________________
niese.jpg

Detlef Niese, Novartis

“The PharmaTrain project is built on a partnership between industry, academia and other professional bodies. It offers a unique opportunity for all of us in Europe to accellerate the process of developing more innovative, safer and more effective medicines – more economically. This is an opportunity we must not miss.”

_______________________________________________________________
Gottwald_Matthias_150x110.png

Matthias Gottwald, Bayer Pharma

“The PharmaTrain programmes are offered in a modular format. This does not only foster mobility of master students across Europe but also makes the individual – master level – modules highly attractive for professionals in pharmaceutical companies seeking additional qualification in their continued professional development.”

_______________________________________________________________
Online training in Medicines Development has been recognised by our company almost a decade ago and we have helped to get Hibernia College going. Some of this early experience has paved the way towards creation of Introduction to Medicines Development which PharmaTrain plans to use in all its training programmes as well as a standalone (e1-compact, ECTS point in the PharmaTrain e-library).

Chan_Anthony_Pfizer_150x110.png

Anthony Chan, Pfizer

“Over the last few years, e-teaching technology has become more attractive and more interactive. All training will have some blending with online segment in the future.”

_______________________________________________________________